HempMeds® to Educate Thousands of Global Healthcare Professionals Attending the World Congress on Anti-Aging Medicine on Rapidly Emerging Hemp Cannabidiol (CBD) Industry
SAN DIEGO, CA–(Marketwired – December 08, 2016) – Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that its subsidiary HempMeds® is exhibiting at the 24th annual American Academy of Anti-Aging Medicine World Congress (A4M), with the Company’s extensive portfolio of retail-ready cannabis products featured at the Venetian/Palazzo Hotel in Las Vegas from Dec. 9-11.
HempMeds® representatives will exhibit at booth #1027 the Company’s groundbreaking Real Scientific Hemp Oil™ (RSHO™) including its hemp cannabidiol (CBD) oil raw ingredient and zero-THC Real Scientific Hemp Oil-X™ (RSHO-X™), the first-ever cannabis product to receive approval from the federal government of Mexico for importation. Additionally, the Company will be showcasing their award-winning range of Cannabis Beauty Defined® products that are a unique mixture of CBD hemp oil and a specially formulated mixture of herbs to help protect and nourish the skin.
“We are very fortunate to have the opportunity to attend another A4M Conference and to be able to bring our products to the forefront of this market,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We are proud that our products will be showcased to thousands of the premier anti-aging doctors and experts from around the world. The Company’s goal is to educate and open up a worldwide conversation on CBD from the hemp plant.”
The A4M Conference is dedicated to the advancement of technology to detect, prevent, and treat aging-related disease and to promote research into methods to optimize the human aging process. Patent No. 6630507, awarded to the U.S. Department of Health and Human Services, states that cannabinoids have been found to have antioxidant and anti-aging properties.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
Image Available: http://www.marketwire.com/library/MwGo/2016/12/8/11G124586/Images/MM_1-2438bb0f96c7988fa2c4b483c29b117e.jpg
Image Available: http://www.marketwire.com/library/MwGo/2016/12/8/11G124586/Images/MM_2-ec2d28c60d08a8e2b5444a9e2dc6332a.jpg
Public Relations Contact:
Chief Executive Officer
P. 888-829- 0070
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)
Investor Relations Contact:
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500
Email: [email protected]